PSC
BIOA.WS

Piper Sandler & Co’s BioAmber Inc. BIOA.WS Stock Holding History

Piper Sandler & Co’s Portfolio BIOA.WS Stock Details BIOA.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-14,330
Closed -$23K – 158
2015
Q1 		$23K Buy
14,330
+2,904
+25% +$4.8K 0.01% 107
2014
Q4 		$19K Buy
+11,426
New +$22.9K 0.01% 127
2014
Q2 		– Sell
-40,012
Closed -$87K – 179
2014
Q1 		$87K Buy
+40,012
New +$93.3K 0.08% 88

Other funds holding BIOA.WS

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
ACPU
Arrowgrass Capital Partners (US) Dover, Delaware $380M AUM 20.87% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Piper Sandler & Co's BIOA.WS Position: Q2 2015 in Review

Piper Sandler & Co sold out of BioAmber Inc. (BIOA.WS) in Q2 2015, closing a stake of 14,330 shares — an estimated $23K sold.

Piper Sandler & Co first reported a position in BIOA.WS in Q1 2014 and held it in 3 quarters. The position peaked at $87K in Q1 2014. 8 funds tracked by Wall St. Rank hold BIOA.WS as of Q2 2015.

  • Piper Sandler & Co reported no remaining BioAmber Inc. position as of Q2 2015 after selling out during the quarter.
  • Piper Sandler & Co sold 14,330 BioAmber Inc. shares in Q2 2015, an estimated $23K.
  • Piper Sandler & Co first reported a position in BioAmber Inc. in Q1 2014 and held it in 3 quarters.
  • Piper Sandler & Co's BioAmber Inc. position peaked at $87K in Q1 2014.
  • 8 funds tracked by Wall St. Rank held BioAmber Inc. as of Q2 2015.

Based on Piper Sandler & Co's 13F filing for Q2 2015, filed 14 Aug 2015.